Balyasny Asset Management
MLNT

Balyasny Asset Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Balyasny Asset Management’s Portfolio MLNT Stock Details MLNT Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,047
Closed -$162K – 2167
2017
Q4 		$162K Buy
+2,047
New +$162K ﹤0.01% 1690